1 |
Simoncini GM, Hou Q, Carlson K, Buchacz K, Tedaldi E, Palella F , Jr, Durham M, Li J; HIV Outpatient Study (HOPS) Investigators. Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018. AIDS Patient Care STDS 2021;35:392-400. [PMID: 34623891 DOI: 10.1089/apc.2021.0087] [Reference Citation Analysis]
|
2 |
Falade-Nwulia O, Sulkowski MS, Merkow A, Latkin C, Mehta SH. Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era. J Viral Hepat. 2018;25:220-227. [PMID: 29316030 DOI: 10.1111/jvh.12859] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
|
3 |
Luo BF, Rao HY, Gao YH, Wei L. Risk factors for familial clustering of hepatitis C virus infection in a Chinese Han population: a cross-sectional study. BMC Public Health 2018;18:708. [PMID: 29879949 DOI: 10.1186/s12889-018-5592-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70:1-187. [PMID: 34292926 DOI: 10.15585/mmwr.rr7004a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Laiwatthanapaisan R, Sirinawasatien A. Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults. World J Clin Cases 2021; 9(18): 4491-4499 [PMID: 34222417 DOI: 10.12998/wjcc.v9.i18.4491] [Reference Citation Analysis]
|